175 related articles for article (PubMed ID: 17369487)
1. Stable trichimerism after marrow grafting from 2 DLA-identical canine donors and nonmyeloablative conditioning.
Graves SS; Hogan W; Kuhr CS; Diaconescu R; Harkey MA; Georges GE; Sale GE; Zellmer E; Baran SW; Jochum C; Stone B; Storb R
Blood; 2007 Jul; 110(1):418-23. PubMed ID: 17369487
[TBL] [Abstract][Full Text] [Related]
2. Adoptive immunotherapy against allogeneic kidney grafts in dogs with stable hematopoietic trichimerism.
Graves SS; Hogan WJ; Kuhr C; Diaconescu R; Harkey M; Sale GE; Stone B; Georges GE; Storb R
Biol Blood Marrow Transplant; 2008 Nov; 14(11):1201-8. PubMed ID: 18940673
[TBL] [Abstract][Full Text] [Related]
3. Hematopoietic chimerism induces renal and skin allograft tolerance in DLA-identical dogs.
Tillson M; Niemeyer GP; Welch JA; Brawner W; Swaim SF; Rynders P; Lenz SD; Dean B; Lothrop CD
Exp Hematol; 2006 Dec; 34(12):1759-70. PubMed ID: 17157174
[TBL] [Abstract][Full Text] [Related]
4. Renal allograft tolerance in DLA-identical and haploidentical dogs after nonmyeloablative conditioning and transient immunosuppression with cyclosporine and mycophenolate mofetil.
Niemeyer GP; Welch JA; Tillson M; Brawner W; Rynders P; Goodman S; Dufresne M; Dennis J; Lothrop CD
Transplant Proc; 2005 Dec; 37(10):4579-86. PubMed ID: 16387175
[TBL] [Abstract][Full Text] [Related]
5. CD154 blockade and donor-specific transfusions in DLA-identical marrow transplantation in dogs conditioned with 1-Gy total body irradiation.
Jochum C; Beste M; Zellmer E; Graves SS; Storb R
Biol Blood Marrow Transplant; 2007 Feb; 13(2):164-71. PubMed ID: 17241922
[TBL] [Abstract][Full Text] [Related]
6. Long-term tolerance to kidney allografts after induced rejection of donor hematopoietic chimerism in a preclinical canine model.
Graves SS; Mathes DW; Georges GE; Kuhr CS; Chang J; Butts TM; Storb R
Transplantation; 2012 Sep; 94(6):562-8. PubMed ID: 22929594
[TBL] [Abstract][Full Text] [Related]
7. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation.
Storb R; Yu C; Wagner JL; Deeg HJ; Nash RA; Kiem HP; Leisenring W; Shulman H
Blood; 1997 Apr; 89(8):3048-54. PubMed ID: 9108426
[TBL] [Abstract][Full Text] [Related]
8. Failure of donor lymphocyte infusion to prevent graft rejection in dogs given DLA-identical marrow after 1 Gy of total body irradiation.
Baron F; Sandmaier BM; Zellmer E; Sorror M; Storer B; Storb R
Biol Blood Marrow Transplant; 2006 Aug; 12(8):813-7. PubMed ID: 16864051
[TBL] [Abstract][Full Text] [Related]
9. Canine bone marrow-derived mesenchymal stromal cells suppress alloreactive lymphocyte proliferation in vitro but fail to enhance engraftment in canine bone marrow transplantation.
Lee WS; Suzuki Y; Graves SS; Iwata M; Venkataraman GM; Mielcarek M; Peterson LJ; Ikehara S; Torok-Storb B; Storb R
Biol Blood Marrow Transplant; 2011 Apr; 17(4):465-75. PubMed ID: 20457265
[TBL] [Abstract][Full Text] [Related]
10. Dog leukocyte antigen-haploidentical stem cell allografts after anti-CD44 therapy and nonmyeloablative conditioning in a preclinical canine model.
Fukuda T; Kerbauy FR; Gooley T; Santos EB; Storb R; Sandmaier BM
Transplantation; 2006 Aug; 82(3):332-9. PubMed ID: 16906030
[TBL] [Abstract][Full Text] [Related]
11. Postgrafting immunosuppression with sirolimus and cyclosporine facilitates stable mixed hematopoietic chimerism in dogs given sublethal total body irradiation before marrow transplantation from DLA-identical littermates.
Hogan WJ; Little MT; Zellmer E; Friedetzky A; Diaconescu R; Gisburne S; Lee R; Kuhr C; Storb R
Biol Blood Marrow Transplant; 2003 Aug; 9(8):489-95. PubMed ID: 12931117
[TBL] [Abstract][Full Text] [Related]
12. Induction of allogeneic unresponsiveness in adult dogs. Role of non-DLA histocompatibility variables in conditioning the outcome of bone marrow, kidney, and skin transplantation in radiation chimeras.
Rapaport FT; Bachvaroff RJ; Watanabe K; Hirasawa H; Mollen N; Ferrebee JW; Amos DB; Cannon FD; Blumenstock DA
J Clin Invest; 1978 Mar; 61(3):790-800. PubMed ID: 76636
[TBL] [Abstract][Full Text] [Related]
13. Stable mixed hematopoietic chimerism in dog leukocyte antigen-identical littermate dogs given lymph node irradiation before and pharmacologic immunosuppression after marrow transplantation.
Storb R; Yu C; Barnett T; Wagner JL; Deeg HJ; Nash RA; Kiem HP; McSweeney P; Seidel K; Georges G; Zaucha JM
Blood; 1999 Aug; 94(3):1131-6. PubMed ID: 10419907
[TBL] [Abstract][Full Text] [Related]
14. Adoptive immunotherapy against kidney targets in dog-leukocyte antigen-identical mixed hematopoietic canine chimeras.
Junghanss C; Takatu A; Little MT; Maciej Zaucha J; Zellmer E; Yunusov M; Sale G; Georges GE; Storb R
Transplantation; 2003 Feb; 75(3):268-74. PubMed ID: 12589144
[TBL] [Abstract][Full Text] [Related]
15. Adoptive immunotherapy to increase the level of donor hematopoietic chimerism after nonmyeloablative marrow transplantation for severe canine hereditary hemolytic anemia.
Takatu A; Nash RA; Zaucha JM; Little MT; Georges GE; Sale GE; Zellmer E; Kuhr CS; Lothrop CD; Storb R
Biol Blood Marrow Transplant; 2003 Nov; 9(11):674-82. PubMed ID: 14652850
[TBL] [Abstract][Full Text] [Related]
16. Safety of treatment with DLA-identical or unrelated mesenchymal stromal cells in DLA-identical canine bone marrow transplantation.
Kornblit B; Leisenring WM; Santos EB; Storb R; Sandmaier BM
Chimerism; 2013; 4(3):95-101. PubMed ID: 23723082
[TBL] [Abstract][Full Text] [Related]
17. Bismuth 213-labeled anti-CD45 radioimmunoconjugate to condition dogs for nonmyeloablative allogeneic marrow grafts.
Sandmaier BM; Bethge WA; Wilbur DS; Hamlin DK; Santos EB; Brechbiel MW; Fisher DR; Storb R
Blood; 2002 Jul; 100(1):318-26. PubMed ID: 12070043
[TBL] [Abstract][Full Text] [Related]
18. Tolerance to vascularized composite allografts in canine mixed hematopoietic chimeras.
Mathes DW; Hwang B; Graves SS; Edwards J; Chang J; Storer BE; Butts-Miwongtum T; Sale GE; Nash RA; Storb R
Transplantation; 2011 Dec; 92(12):1301-8. PubMed ID: 22082819
[TBL] [Abstract][Full Text] [Related]
19. G-CSF-mobilized peripheral blood mononuclear cells added to marrow facilitates engraftment in nonmyeloablated canine recipients: CD3 cells are required.
Zaucha JM; Zellmer E; Georges G; Little MT; Storb R; Storer B; Torok-Storb B
Biol Blood Marrow Transplant; 2001; 7(11):613-9. PubMed ID: 11760149
[TBL] [Abstract][Full Text] [Related]
20. Effects of extending the duration of postgrafting immunosuppression and substituting granulocyte-colony-stimulating factor-mobilized peripheral blood mononuclear cells for marrow in allogeneic engraftment in a nonmyeloablative canine transplantation model.
Zaucha JM; Yu C; Zellmer E; Takatu A; Junghanss C; Little MT; Storb R
Biol Blood Marrow Transplant; 2001; 7(9):513-6. PubMed ID: 11669218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
